WestChina-Frontier's cellular immunology team has impressive disciplinary background in medical immunology, cytobiology and electrophysiology; the laboratories are equipped with advanced instruments and analysis software, establishing a leading biomarker analysis platform in China, an in vitro cardiac safety evaluation hERG technology platform based on manual patch clamp, a stem cell and organoid platform, a Comprehensive in vitro Proarrhythmia Assay (CiPA) system for human stem cell differentiated cadiocytes, and an in vitro phototoxicity evaluation system, which provides new approaches to safety evaluation of drugs in the future.
Cytokines: IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17, GM-CSF, TNF-α, IFN-γ, etc.;
Immunoglobulins: IgA, IgG, IgM, IgE, etc.;
Hormones: insulins, TSH, T3, T4, FSH, GH, E2, T, LH, PRL, cortisol, crtisone, etc.;
Others: HYP, VEGF, MMP, CRP, EPO, etc.
• Adequate background data for drug-induced cytokine release in human PBMCs by solid phase and liquid phase methods;
• High-energy, high-sensitivity, and wide-linearity assay of cytokines in samples of small size to address the limitations of conventional ELISA;
• Powerful data analysis capability with individualized data interpretation services;
• Diversified blood sample acquisition routes with complete ethical qualification information;
• Rapid and efficient extraction of PBMCs from human and monkey blood samples.
• hERG channel
• Multi-electrode array (MEA) assay of cadiocytes
· Compound photoabsorption test;
· In vitro 3T3 neutral red uptake (NRU) assay
Business Contacts:028-60662528
E-mail:service@glpcd.com
+8628-60662518-8800
+8628-85154334-800